Annual SGA
$1.43 B
+$585.27 M+68.98%
March 31, 2024
Summary
- As of March 5, 2025, RDY annual SGA is $1.43 billion, with the most recent change of +$585.27 million (+68.98%) on March 31, 2024.
- During the last 3 years, RDY annual SGA has risen by +$698.92 million (+95.12%).
- RDY annual SGA is now at all-time high.
Performance
RDY SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$285.47 M
+$10.84 M+3.95%
December 31, 2024
Summary
- As of March 5, 2025, RDY quarterly SGA is $285.47 million, with the most recent change of +$10.84 million (+3.95%) on December 31, 2024.
- Over the past year, RDY quarterly SGA has increased by +$42.53 million (+17.51%).
- RDY quarterly SGA is now at all-time high.
Performance
RDY Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
$13.42 B
+$469.88 M+3.63%
December 31, 2024
Summary
- As of March 5, 2025, RDY TTM SGA is $13.42 billion, with the most recent change of +$469.88 million (+3.63%) on December 31, 2024.
- Over the past year, RDY TTM SGA has increased by +$12.52 billion (+1383.63%).
- RDY TTM SGA is now at all-time high.
Performance
RDY TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RDY Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +69.0% | +17.5% | +1383.6% |
| 3 y3 years | +95.1% | +37.0% | +1510.9% |
| 5 y5 years | +106.0% | +37.0% | +1510.9% |
RDY Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.1% | at high | +42.2% | at high | +50.7% |
| 5 y | 5-year | at high | +106.0% | at high | +70.3% | at high | +73.6% |
| alltime | all time | at high | +2234.0% | at high | +1719.9% | at high | >+9999.0% |
Dr Reddys Laboratories Limited Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $285.47 M(+3.9%) | $806.66 M(+5.6%) |
| Sep 2024 | - | $274.63 M(+11.4%) | $764.13 M(-18.0%) |
| Mar 2024 | $1.43 B(+69.0%) | $246.56 M(+1.5%) | $932.28 M(+3.0%) |
| Dec 2023 | - | $242.94 M(+6.9%) | $904.75 M(+2.7%) |
| Sep 2023 | - | $227.31 M(+5.5%) | $880.78 M(+2.3%) |
| Jun 2023 | - | $215.47 M(-1.6%) | $861.05 M(+1.7%) |
| Mar 2023 | $848.46 M(+1.8%) | $219.04 M(+0.0%) | $846.39 M(+1.3%) |
| Dec 2022 | - | $218.97 M(+5.5%) | $835.76 M(+1.6%) |
| Sep 2022 | - | $207.57 M(+3.4%) | $822.38 M(-0.9%) |
| Jun 2022 | - | $200.81 M(-3.6%) | $830.08 M(-0.4%) |
| Mar 2022 | $833.38 M(+13.4%) | $208.40 M(+1.4%) | $833.27 M(+1.4%) |
| Dec 2021 | - | $205.59 M(-4.5%) | $821.94 M(+1.4%) |
| Sep 2021 | - | $215.27 M(+5.5%) | $810.88 M(+5.1%) |
| Jun 2021 | - | $204.01 M(+3.5%) | $771.45 M(+4.9%) |
| Mar 2021 | $734.81 M(+4.1%) | $197.07 M(+1.3%) | $735.26 M(+4.2%) |
| Dec 2020 | - | $194.53 M(+10.6%) | $705.87 M(+2.4%) |
| Sep 2020 | - | $175.84 M(+4.8%) | $689.05 M(-1.7%) |
| Jun 2020 | - | $167.83 M(+0.1%) | $700.61 M(-0.8%) |
| Mar 2020 | $705.90 M(+1.4%) | $167.68 M(-5.6%) | $705.94 M(-1.1%) |
| Dec 2019 | - | $177.70 M(-5.2%) | $713.75 M(+1.5%) |
| Sep 2019 | - | $187.40 M(+8.2%) | $702.88 M(+1.6%) |
| Jun 2019 | - | $173.16 M(-1.3%) | $691.82 M(-1.1%) |
| Mar 2019 | $695.89 M(-4.3%) | $175.49 M(+5.2%) | $699.25 M(-1.7%) |
| Dec 2018 | - | $166.82 M(-5.4%) | $711.28 M(-2.7%) |
| Sep 2018 | - | $176.35 M(-2.4%) | $730.68 M(+0.7%) |
| Jun 2018 | - | $180.59 M(-3.7%) | $725.94 M(-0.2%) |
| Mar 2018 | $726.80 M(+5.1%) | $187.52 M(+0.7%) | $727.73 M(+3.4%) |
| Dec 2017 | - | $186.22 M(+8.5%) | $704.03 M(+2.6%) |
| Sep 2017 | - | $171.60 M(-5.9%) | $686.07 M(-0.6%) |
| Jun 2017 | - | $182.38 M(+11.3%) | $690.35 M(-0.2%) |
| Mar 2017 | $691.53 M(-1.0%) | $163.83 M(-2.6%) | $691.57 M(-1.2%) |
| Dec 2016 | - | $168.26 M(-4.3%) | $700.04 M(-2.0%) |
| Sep 2016 | - | $175.89 M(-4.2%) | $714.41 M(+0.8%) |
| Jun 2016 | - | $183.59 M(+6.6%) | $708.85 M(+1.5%) |
| Mar 2016 | $698.63 M(+0.3%) | $172.30 M(-5.7%) | $698.31 M(+1.5%) |
| Dec 2015 | - | $182.62 M(+7.2%) | $687.97 M(+0.4%) |
| Sep 2015 | - | $170.34 M(-1.6%) | $685.35 M(-0.8%) |
| Jun 2015 | - | $173.05 M(+6.8%) | $691.07 M(-0.8%) |
| Mar 2015 | $696.66 M(+8.2%) | $161.96 M(-10.0%) | $696.56 M(-0.7%) |
| Dec 2014 | - | $180.00 M(+2.2%) | $701.39 M(+2.9%) |
| Sep 2014 | - | $176.06 M(-1.4%) | $681.74 M(+2.9%) |
| Jun 2014 | - | $178.54 M(+7.0%) | $662.46 M(+3.2%) |
| Mar 2014 | $643.64 M(+2.1%) | $166.79 M(+4.0%) | $641.85 M(-1.1%) |
| Dec 2013 | - | $160.36 M(+2.3%) | $648.69 M(+0.3%) |
| Sep 2013 | - | $156.77 M(-0.7%) | $646.57 M(+1.8%) |
| Jun 2013 | - | $157.93 M(-9.0%) | $634.98 M(+0.7%) |
| Mar 2013 | $630.57 M | $173.64 M(+9.7%) | $630.58 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | - | $158.23 M(+9.0%) | $591.16 M(+1.2%) |
| Sep 2012 | - | $145.18 M(-5.4%) | $584.28 M(-2.1%) |
| Jun 2012 | - | $153.54 M(+14.4%) | $597.05 M(+0.4%) |
| Mar 2012 | $626.76 M(+20.5%) | $134.21 M(-11.3%) | $594.73 M(-0.2%) |
| Dec 2011 | - | $151.35 M(-4.2%) | $596.05 M(+1.5%) |
| Sep 2011 | - | $157.95 M(+4.5%) | $587.03 M(+6.3%) |
| Jun 2011 | - | $151.21 M(+11.6%) | $551.99 M(+6.0%) |
| Mar 2011 | $520.35 M(+9.5%) | $135.54 M(-4.8%) | $520.97 M(+1.7%) |
| Dec 2010 | - | $142.33 M(+15.8%) | $512.19 M(+5.3%) |
| Sep 2010 | - | $122.91 M(+2.3%) | $486.49 M(+2.6%) |
| Jun 2010 | - | $120.19 M(-5.2%) | $473.97 M(-0.3%) |
| Mar 2010 | $475.14 M(+3.7%) | $126.75 M(+8.7%) | $475.49 M(+4.5%) |
| Dec 2009 | - | $116.64 M(+5.7%) | $454.89 M(+1.3%) |
| Sep 2009 | - | $110.38 M(-9.3%) | $448.85 M(-2.1%) |
| Jun 2009 | - | $121.72 M(+14.7%) | $458.25 M(-0.1%) |
| Mar 2009 | $458.01 M(+9.0%) | $106.15 M(-4.0%) | $458.61 M(-2.7%) |
| Dec 2008 | - | $110.59 M(-7.7%) | $471.33 M(+1.2%) |
| Sep 2008 | - | $119.78 M(-1.9%) | $465.56 M(+7.2%) |
| Jun 2008 | - | $122.08 M(+2.7%) | $434.11 M(+8.7%) |
| Mar 2008 | $420.09 M(+34.4%) | $118.87 M(+13.4%) | $399.42 M(+11.3%) |
| Dec 2007 | - | $104.83 M(+18.7%) | $358.78 M(+7.2%) |
| Sep 2007 | - | $88.33 M(+1.1%) | $334.61 M(+2.9%) |
| Jun 2007 | - | $87.39 M(+11.7%) | $325.33 M(+4.3%) |
| Mar 2007 | $312.59 M(+71.4%) | $78.23 M(-3.0%) | $311.92 M(+9.1%) |
| Dec 2006 | - | $80.66 M(+2.0%) | $286.00 M(+14.4%) |
| Sep 2006 | - | $79.05 M(+6.9%) | $249.96 M(+18.2%) |
| Jun 2006 | - | $73.98 M(+41.4%) | $211.53 M(+15.4%) |
| Mar 2006 | $182.43 M(+20.5%) | $52.31 M(+17.2%) | $183.30 M(+2.2%) |
| Dec 2005 | - | $44.62 M(+9.8%) | $179.33 M(+5.4%) |
| Sep 2005 | - | $40.62 M(-11.2%) | $170.12 M(+1.8%) |
| Jun 2005 | - | $45.75 M(-5.3%) | $167.05 M(+5.7%) |
| Mar 2005 | $151.43 M(+5.7%) | $48.33 M(+36.5%) | $158.05 M(+1.2%) |
| Dec 2004 | - | $35.41 M(-5.7%) | $156.11 M(+0.9%) |
| Sep 2004 | - | $37.55 M(+2.2%) | $154.76 M(+3.7%) |
| Jun 2004 | - | $36.75 M(-20.8%) | $149.29 M(+3.9%) |
| Mar 2004 | $143.21 M(+38.5%) | $46.40 M(+36.2%) | $143.75 M(+12.1%) |
| Dec 2003 | - | $34.06 M(+6.1%) | $128.25 M(+5.3%) |
| Sep 2003 | - | $32.09 M(+2.9%) | $121.73 M(+5.4%) |
| Jun 2003 | - | $31.20 M(+1.0%) | $115.49 M(+11.5%) |
| Mar 2003 | $103.37 M(+34.8%) | $30.90 M(+12.1%) | $103.62 M(+10.5%) |
| Dec 2002 | - | $27.55 M(+6.6%) | $93.76 M(+8.2%) |
| Sep 2002 | - | $25.85 M(+33.8%) | $86.69 M(+8.0%) |
| Jun 2002 | - | $19.32 M(-8.2%) | $80.28 M(+4.7%) |
| Mar 2002 | $76.70 M(+24.9%) | $21.04 M(+2.8%) | $76.65 M(+37.8%) |
| Dec 2001 | - | $20.48 M(+5.3%) | $55.61 M(+58.3%) |
| Sep 2001 | - | $19.44 M(+24.0%) | $35.13 M(+124.0%) |
| Jun 2001 | - | $15.69 M | $15.69 M |
| Mar 2001 | $61.43 M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual SGA?
- What is the all time high annual SGA for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual SGA year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly SGA?
- What is the all time high quarterly SGA for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly SGA year-on-year change?
- What is Dr Reddys Laboratories Limited TTM SGA?
- What is the all time high TTM SGA for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM SGA year-on-year change?
What is Dr Reddys Laboratories Limited annual SGA?
The current annual SGA of RDY is $1.43 B
What is the all time high annual SGA for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual SGA is $1.43 B
What is Dr Reddys Laboratories Limited annual SGA year-on-year change?
Over the past year, RDY annual SGA has changed by +$585.27 M (+68.98%)
What is Dr Reddys Laboratories Limited quarterly SGA?
The current quarterly SGA of RDY is $285.47 M
What is the all time high quarterly SGA for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly SGA is $285.47 M
What is Dr Reddys Laboratories Limited quarterly SGA year-on-year change?
Over the past year, RDY quarterly SGA has changed by +$42.53 M (+17.51%)
What is Dr Reddys Laboratories Limited TTM SGA?
The current TTM SGA of RDY is $13.42 B
What is the all time high TTM SGA for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM SGA is $13.42 B
What is Dr Reddys Laboratories Limited TTM SGA year-on-year change?
Over the past year, RDY TTM SGA has changed by +$12.52 B (+1383.63%)